Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Apr 06, 2021 1:59pm
111 Views
Post# 32942650

RE:RE:RE:RE:News!

RE:RE:RE:RE:News!

Redbaron2211 wrote: Yes not dismissing potential catalysts between now and June we know there are much larger catalysts lurking.


Rose I mean Red ,

The sp is capped due to fumbling management .  Canacorrd exercise price is $3.05 which allows for force conversion . On top Of that you have two sets of warrants due basically at the same time in 2022 which will be another 10 to 12 million plus 20 million canacorrd ones. Toleikis even gave 15% over allotment plus 2% for legal fees.... lol ....

Any news in the next few months will be sold under $3 by previous longs who were loyal in my opinion .  This is reality  Red .

I doubt you see above $3 anytime soon . Tolekis messed that up good.  Still has not come forward to tell us exactly why he was in such a rush to do the financing ?


Maybe you can ask him and Dominic . Ask them when AGM is . I bet they will be elusive .

Ms Sally 
 

<< Previous
Bullboard Posts
Next >>